PRACTIAL N PN 138/PRN Drug Classification _Cards,100% CORRECT

PRACTIAL N PN 138/PRN Drug Classification _Cards Classification: Anti-Convulsent Pregnancy Category C (mood stabilizer) Client Uses: 1. Partial Seizures (adjunct treatment) (immediate release only). 2. Postherapetic neuralgia. 3. Restless leg syndrome (Horizant only). 4.Neuro-pathic pain 5. Prevention of migraine headache. 6. Bipolar disorder. 7.Anxiety 8.Diabetic peripheral neuropathy. Assessments/ Monitoring: 1 .Monitor closely for notable changes in behavior that could indicate the emergence or worsening of suicidal thoughts or behavior or depression. 2. Seizures: Assess location, duration, and characteristics of seizure activity. 3. Posttherpetic Neuralgia & Neuropathic Pain: Assess location, characteristics, and intensity, of pain periodically during therapy. 4. Migraine Prophylaxis: Monitor frequency and intensity of pain on pain scale. 5. Restless Leg Syndrome: Assess frequency and intensity of restless leg syndrome prior to and periodically during therapy. Side Effects: CNS: dal thoughts sion ssion ness iness ion ty ntration difficulties (children) onal lability (children) lity kubesia (children) se go ess EENT: 1. abnormal vision 2. nystagmus CV: tension GI: t gain xia lence vitis Client Teaching: 1. Instruct patient to take medication exactly as directed. Patients on tid dosing should not exceed 12 hr between doses. Take missed dose asap, if less than 2 hr until next dose, take dose immediately and take next dose 1-2 hr later, then resume regular dosing schedule. 2. Advise patient not to take gabapentin within 2 hr of antacid. 3. Advise patient and family to notify healthcare professional if thoughts about suicide or dying, attempts to commit suicide, new or worse depression, anxiety. 4. Advise female patients to notify healthcare professional if pregnancy is planned or suspected or if breast feeding. 5. Advise patient to carry identification describing disease process and medication regimen at all times. Medication Names: List both: Generic Name Brand or Trade Name Gabapentin Neurontin Reference:Deglan, J.D. & Vallerand, A.H. 2013. Davis Drug Guide for Nurses, 14th ed.F.A. Davis, Philadelphia. Page # 601,602 This study s Medication Names: List both: Generic Name Brand or Trade Name Fluoxetine Prozac Reference:Deglan, J.D. & Vallerand, A.H. 2013. Davis Drug Guide for Nurses, 14th ed. F.A. Davis, Philadelphia. Page # 578,579 Client Uses: 1. Adjunct in the management of: Anxiety disorder. 2. Athetosis 3. Anxiety relief prior to cardioversion (injection). 4. Stiffman syndrome. 5. Preoperative sedation. 6. Conscious sedation (provides light anesthesia and anterograde amnesia). 7. Treatment of status epilepticus/ uncontrontrolled seizures (injection). 8.Skeletal Muscle relaxant 9. Management of alcohol withdrawal. Assessments/ Monitoring: 1. Monitor BP, pulse, and respiratory rate prior to and periodically throughout therapy and frequently during IV therapy. 2. Anxiety: Assess mental status (orientation, mood, behavior) and degree of anxiety. 3. Seizures: Observe and record intensity, duration, and location of seizure activity. The initial dose of diazepam offers seizure control for 15-20 minutes after administration. 4. Muscle Spasms: Assess muscle spasms, associated pain, and limitation of movement prior to and during therapy. 5. Alcohol Withdrawal: Assess patient experiencing alcohol withdrawal for tremors, agitation, delirium, and hallucinations. Protect patient from injury. Side Effects: CNS: ness iness rgy ssion ver a ed speech che EENT: 1.Blurred vision RESP: 1.Respiratory depression CV: ension (IV only) GI: ipation hea 3.Nausea 4.Vomitting 5.Weight gain DERM: s Client Teaching: 1. Instruct patient to take medication as directed and not to take more than prescribed or increase dose if less effective after a few weeks without checking with health care professional. 2. Medication may cause drowsiness, clumsiness, or unsteadiness. Advise patient to avoid driving or other activities requiring alertness until response to medication is known. 3. Caution patient to avoid taking alcohol taking alcohol or other CNS depressants concurrently with this medication. 4. Emphasize the importance of follow- up examinations to determine effectiveness of the medication. 5.Seizures: Patients on anti-convulsant therapy should carry identification describing disease process and medication regimen at all times. Medication Names: List both: Generic Name Brand or Trade Name Diazepam Valium Reference:Deglan, J.D. & Vallerand, A.H. 2013. Davis Drug Guide for Nurses, 14th ed. F.A. Davis, Philadelphia. Page # 414,415,416 Client Uses: 1. Schizophrenia 2. Depressive episodes with bipolar disorder. 3. Acute manic episodes associated with bipolar I disorder (as monotherapy for adults or adolescents) or with lithium or divalproex (adults only). 4. Maintenance treatment of bipolar I disorder (with lithium or divalproex) 5. Adjunctive treatment of depression. Assessments/ Monitoring: 1. Monitor mental status (mood, orientation, behavior) before and periodically during therapy. 2. Assess for suicidal tendencies, especially during early therapy. 3. Monitor for development of neuroleptic malignant syndrome (fever, respiratory distress, tachycardia, seizures, diaphoresis, hypertension or hypotension pallor, tiredness) Notify health care professional immediately if these symptoms occur. 4. Assess for rash periodically during therapy. May cause Stevens- Johnson syndrome. Discontinue therapy if severe or if accompanied with fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, hepatitis, and or eosinophilia. 5. Monitor for signs of pancreatitis (nausea, vomiting, anorexia, persistent severe abdominal pain, sometimes radiating to the back) during thereapy. Side Effects: CNS: 1. Neuroleptic Malignant Syndrome 2. Seizures ness tive impairment 5. extra pyramidal symptoms ions ve dyskinesia EENT: 1. ear pain 2. rhinitis ngitis RESP: ea CV: ase blood pressure (children) tions eral edema ral hypotension GI: eatitis xia ipation uth psia DERM: 1. Stevens-Johnson Syndrome 2. sweating Client Teaching: 1. Advise patient to change positions slowly to minimize orthostatic hypotension. 2. Advise patient to avoid extreme temperature; this drug impairs body temperature regulation. 3. Advise patient and family to notify health care professional if thoughts about suicide or dying, attempts to commit suicide, new or worsen depression, new or worse anxiety, feeling very agitated or restless, panic attacks, trouble sleeping, new or worse irritability, acting aggressive, being angry or violent, acting on dangerous impulses, an extreme increase in activity and talking, other unusual changes in behavior or mood occur. 4. Refer patient for nutritional, weight, or medical management of dyslipidemia as indicated. 5. Instruct patient to notify health care professional promptly of sore throat, fever, unusual bleeding, or bruising, or rash. Medication Names: List both: Generic Name Brand or Trade Name Quetiapine Seroquel